Evidence map›Paper›PMID 28255773›Full record

ArticleCell and tissue banking2017

Cell lines authentication and mycoplasma detection as minimun quality control of cell lines in biobanking.

C Corral-Vázquez, R Aguilar-Quesada, P Catalina, G Lucena-Aguilar, G Ligero, B Miranda, J A Carrillo-Ávila

Open access · hybridAbstract read
In one paragraph

Article in Cell and tissue banking, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. A Clonogenic Assay to Quantify Melanoma Micrometastases in Pulmonary Tissue.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  12. Biobanks-A Platform for Scientific and Biomedical Research.Diagnostics (Basel, Switzerland) · 2020
    Review
  13. Article
  14. Article
  15. Article
  16. Biobanking in health care: evolution and future directions.Journal of translational medicine · 2019
    Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

C Corral-VázquezAndalusian Public Health System Biobank, Avenida Del Conocimiento S/N, 18016, Granada, Spain.ORCID http://orcid.org/0000-0003-0230-3067
R Aguilar-QuesadaAndalusian Public Health System Biobank, Avenida Del Conocimiento S/N, 18016, Granada, Spain.
P CatalinaAndalusian Public Health System Biobank, Avenida Del Conocimiento S/N, 18016, Granada, Spain.
G Lucena-AguilarAndalusian Public Health System Biobank, Avenida Del Conocimiento S/N, 18016, Granada, Spain.
G LigeroAndalusian Public Health System Biobank, Avenida Del Conocimiento S/N, 18016, Granada, Spain.
B MirandaAndalusian Public Health System Biobank, Avenida Del Conocimiento S/N, 18016, Granada, Spain.
J A Carrillo-ÁvilaAndalusian Public Health System Biobank, Avenida Del Conocimiento S/N, 18016, Granada, Spain. jantonio.carrillo@juntadeandalucia.es.
Andalusian School of Public Health · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Establishment of continuous cell lines from human normal and tumor tissues is an extended and useful methodology for molecular characterization of cancer pathophysiology and drug development in research laboratories. The exchange of these cell lines between different labs is a common practice that can compromise assays reliability due to contamination with microorganism such as mycoplasma or cells from different flasks that compromise experiment reproducibility and reliability. Great proportions of cell lines are contaminated with mycoplasma and/or are replaced by cells derived for a different origin during processing or distribution process. The scientific community has underestimated this problem and thousand of research experiment has been done with cell lines that are incorrectly identified and wrong scientific conclusions have been published. Regular contamination and authentication tests are necessary in order to avoid negative consequences of widespread misidentified and contaminated cell lines. Cell banks generate, store and distribute cell lines for research, being mandatory a consistent and continuous quality program. Methods implementation for guaranteeing both, the absence of mycoplasma and authentication in the supplied cell lines, has been performed in the Andalusian Health System Biobank. Specifically, precise results were obtained using real time PCR detection for mycoplasma and 10 STRs identification by capillary electrophoresis for cell line authentication. Advantages and disadvantages of these protocols are discussed.

Indexed as

Biological Specimen BanksCell Culture TechniquesCell LineDNA, BacterialHumansMycoplasmaMycoplasma InfectionsPolymerase Chain ReactionQuality ControlDNA, BacterialBiobankingCell line authenticationMycoplasmaPCRQuality controlSTRs

Identifiers

PMID28255773
PMCPMC5429902
OpenAlexW2592131051

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.